Short answer: A UK IPL or laser hair-removal offer should say exactly what the evidence supports, not compress different outcomes into “permanent,” “pain-free” or “works for everyone.” The Committee of Advertising Practice (CAP) advises marketers to hold robust clinical evidence for hair-removal-device efficacy and to make clear whether a service uses laser or intense pulsed light (IPL). Buyers who plan to resell, private-label or operate equipment should review the supplier’s claims before those words reach a website or treatment menu.
Reduction is not the same as total removal
CAP’s hair-removal advice describes Advertising Standards Authority (ASA) decisions involving real advertisements. In a 2023 case concerning an IPL product, the ASA examined evidence for “permanent visible hair removal” and concluded that a reduction in regrowing hairs with regular treatments did not show that repeated use eventually stopped all regrowth in the treated area. In a 2025 case, the ASA considered evidence for an IPL listing’s “permanent hair reduction in just 12 weeks” and “pain-free IPL” claims insufficient, while accepting that the advertiser could substantiate a treatment-window dimension. Those outcomes are about the named advertisers and submitted evidence, not a verdict on all IPL devices or on TUOKE.
For procurement, treat each phrase as a separate claim with a separate evidence file. A dimensional statement may be tested by measurement; an outcome claim needs a study relevant to the proposed device and schedule. Ask what “permanent” means in the data, what follow-up period was observed, and whether the result was measured after treatment stopped or only during continued use. If a study reports average change, avoid turning it into a promise for every customer. CAP notes that efficacy can vary with skin and hair characteristics, so broad claims across all consumers deserve careful scrutiny.
Audit the whole customer journey
Check product titles, comparison tables, social posts, before-and-after imagery, service menus, staff scripts and translated listings. If one page accurately says “hair reduction” but another says “permanent removal,” the inconsistency will still shape customer expectations. Ask the supplier to identify whether a demonstration was performed with a laser or IPL model, and do not use a laser study to support an IPL claim without a defensible scientific bridge. Training materials should tell operators how to discuss a realistic course of treatment, possible variability and the limits of their own device’s evidence.
A cautious wording review does not require timid, meaningless copy. It requires specific, testable claims anchored to the exact model and intended users. A marketer can explain features and the documented treatment protocol without implying painlessness or guaranteed outcomes. Qualified advertising and clinical reviewers should sign off on higher-risk claims before launch.
Limits and date
CAP’s page is AdviceOnline material dated 11 August 2025, drawing on several historical rulings. It says the advice is not legal advice and does not bind the ASA. It is not a new 2026 ruling and does not establish the safety, approval or efficacy of any TUOKE device. UK marketers must check current rules and the evidence for their own campaign. This article is an independent buyer checklist, not a legal conclusion about a specific advertisement.
See the optical aesthetic equipment insights archive for more jurisdiction-specific context.
Source
- UK CAP, Hair: Hair removal, dated 11 August 2025; reviewed 12 October 2026.